# Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects

> **NCT01764425** · PHASE1 · TERMINATED · sponsor: **Piramal Enterprises Limited** · enrollment: 32 (actual)

## Conditions studied

- Healthy, Overweight and/or Obese Subjects

## Interventions

- **DRUG:** P7435

## Key facts

- **NCT ID:** NCT01764425
- **Lead sponsor:** Piramal Enterprises Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2012-09
- **Final completion:** 2013-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2013-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01764425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01764425, "Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01764425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*